Vivo Capital »

Avalo Therapeutics Ord shares owned by Vivo Capital

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.1M 275k 18.48

More positions owned by Vivo Capital

Trevi Therapeutics Common (TRVI)
Praxis Precision Medicines Common (PRAX)
Erasca Common (ERAS)
Arrivent BioPharma Common (AVBP)
Abivax SA - Sponsored Ads (ABVX)
Tango Therapeutics Common (TNGX)
Corvus Pharmaceuticals Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Tenax Therapeutics Common (TENX)
Aclaris Therapeutics Common (ACRS)
Dyne Therapeutics Common (DYN)
Dianthus Therapeutics Common (DNTH)
Alto Neuroscience Common (ANRO)
DBV Technologies SA Sponsored Ads (DBVT)

View all positions for Vivo Capital

Top funds holding Avalo Therapeutics Ord

FMR
BlackRock
Deep Track Capital
Caligan Partners
TCG Crossover Management
Affinity Asset Advisors
Farallon Capital Management
Point72 Asset Management
venBio Select Advisor
Vanguard Capital Management
BVF
Bank of America Corporation
Nantahala Capital Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Avalo Therapeutics Ord